Major Drugmakers Set To Negotiate Medicare Drug Prices
Bristol Myers Squibb, Janssen Biotech, AstraZeneca, Boehringer Ingelheim and other pharmaceutical companies have agreed to negotiate with the Biden administration under the Inflation Reduction Act's Medicare drug price negotiation provision, the...To view the full article, register now.
Already a subscriber? Click here to view full article